Literature DB >> 33461744

Disorders in the function of Sertoli cells and arrest in the differentiation of gonocytes in patients with cryptochidism and microlithiasis.

Rosa María Vigueras-Villaseñor1, Zayra Ramírez Cuevas2, Margarita Chávez-Saldaña2, Daniel Adrian Landero-Huerta2, Juan Osvaldo Cuevas Alpuche3, Ricardo Antonio Arceo Olaiz3, Julio César Rojas-Castañeda2.   

Abstract

PURPOSE: This study aimed to correlate the presence of microlithiasis (ML) in cryptorchidism (CO) patients with the functionality of Sertoli cells and the arrest of gonocyte differentiation.
METHODS: Testicular biopsies were obtained from 21 inguinal CO pediatric patients and were classified in two groups as follows: patients with ML and those without ML. In both groups, the number of Sertoli cells/seminiferous cords and their functionality were determined, considering the concentrations of inhibin B. In addition, the area and the histological alterations of seminiferous epithelium were evaluated. The arrest of gonocyte differentiation was determined by immunoreactivity to SALL4, AP2ɣ, PLAP and POU5F1.
RESULTS: We found a statistical correlation between the presence of ML with the alterations in the functionality of Sertoli cells without reflecting in the differentiation of the gonocytes.
CONCLUSION: The study of this population suggests that the association between CO and ML shows a malfunction of the Sertoli cells without necessarily causing arrest in the differentiation of gonocytes in these patients.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cryptorchidism; Gonocytes, inhibin B; Microlithiasis; Sertoli cells

Year:  2021        PMID: 33461744     DOI: 10.1016/j.jpedsurg.2020.12.028

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Clinical aspects of histological and hormonal parameters in boys with cryptorchidism: Thesis for PhD degree.

Authors:  Simone Engmann Hildorf
Journal:  APMIS       Date:  2022-07       Impact factor: 3.428

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.